Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Rheumatology

Understanding Lupus Nephritis: Why the Kidneys are Affected

At a Glance

Lupus nephritis occurs when the immune system in systemic lupus erythematosus creates antibody clumps that inflame the kidney’s filters and may cause scarring. Blood and urine tests plus a kidney biopsy help show how active the injury is and guide care.

If you have been diagnosed with Systemic Lupus Erythematosus (SLE), learning that it has begun to affect your kidneys can be deeply unsettling. It is natural to feel a sense of urgency and fear regarding organ damage. This complication, known as Lupus Nephritis (LN), is one of the most serious manifestations of lupus, but understanding why and how it happens is the first step in managing it alongside your medical team.

Who is Affected?

Lupus nephritis occurs when the overactive immune system in SLE targets the kidneys, leading to inflammation and potential scarring. It is a common challenge, affecting approximately 40% to 60% of people with SLE [1][2].

While anyone with lupus can develop kidney involvement, it does not affect everyone equally:

  • Timing: For about 7% to 31% of patients, kidney issues are present at the time of their initial lupus diagnosis [3]. For others, it typically develops within the first five years of the disease [1].
  • Demographics: LN is often more frequent and can be more aggressive in people of non-European ancestry, including Black, Hispanic, and Indigenous populations [4][5]. These observed risk differences reflect a complex mixture of ancestry, geography, socioeconomic factors, and healthcare access [6].
  • Age and Sex: While lupus predominantly affects women, men who develop LN may experience a more severe course of the disease [5]. Children with lupus are also at a higher risk, with 40% to 60% developing kidney involvement, often very early in their diagnosis [7].

The Biology of Kidney Injury

To understand LN, it helps to look at the kidney’s filtration units, called glomeruli. These tiny structures filter waste from your blood. In LN, a “perfect storm” of immune system errors leads to their damage.

1. Accumulation of “Cellular Debris”

In a healthy body, old or damaged cells are cleared away efficiently. In lupus, this process is impaired. Dead cell fragments (nuclear debris) linger, which the immune system mistakenly identifies as “foreign” [8]. This triggers the production of autoantibodies, such as anti-dsDNA, which are designed to attack these fragments [9].

2. Immune Complex “Traffic Jams”

When these autoantibodies bind to the debris, they form clusters called immune complexes. These complexes travel through the bloodstream and get stuck in the fine filters of the kidney [9][10]. Some antibodies may even bind directly to the kidney tissue itself [11].

3. Complement Activation

Once stuck, these complexes activate the complement system—a group of proteins meant to fight infections. While early complement proteins usually help clear debris, in LN, the system becomes overactive and causes “collateral damage” to the kidney’s own cells [12][13]. This leads to intense inflammation and the recruitment of more white blood cells to the area [14].

Specific Areas of Damage

The injury in LN is not limited to one spot. Different parts of the kidney may be affected:

  • Podocytes: These are specialized cells that wrap around the kidney’s filters. When they are injured, they can no longer keep protein in the blood, leading to proteinuria (excess protein in the urine), a hallmark sign of LN [15][16].
  • Tubulointerstitial Area: This is the space between the filters. Inflammation here (tubulointerstitial inflammation) and the resulting scarring (fibrosis) are strong predictors of whether kidney function will decline over time [17][18].

Distinguishing LN from Other Conditions

Because many different diseases can cause kidney inflammation (glomerulonephritis), doctors use specific tools to confirm it is caused by lupus. A kidney biopsy is the gold standard for this. Pathologists look for “full-house” staining—a pattern where multiple different immune proteins (IgG, IgA, IgM, C3, and C1q) are all present in the kidney tissue at once [19][20]. This “full-house” signature, combined with characteristic structural changes seen under a high-powered microscope, helps distinguish LN from other types of kidney disease [19]. While “full-house” staining strongly supports lupus, it is not a standalone diagnosis; it can occasionally occur in infections or other kidney conditions and must be interpreted alongside your biopsy as a whole [21].

Looking Ahead

Current medical guidelines focus on early detection and monitoring to prevent long-term damage. Recent updates to how biopsies are scored help your doctors more accurately measure “activity” (current inflammation that can be reversed) versus “chronicity” (permanent scarring) [22][23]. This information is vital for personalizing your treatment plan and protecting your kidney health for the future.

Common questions in this guide

What causes lupus nephritis in people with lupus?
Lupus nephritis develops when the immune system in systemic lupus erythematosus makes antibodies that attach to cellular debris. The resulting antibody clumps can lodge in the kidney’s filters and activate proteins that intensify inflammation, causing kidney injury and sometimes scarring.
How common is kidney involvement in systemic lupus erythematosus?
About 40% to 60% of people with systemic lupus erythematosus develop lupus nephritis. Kidney involvement may be present when lupus is first diagnosed or may appear during the first five years.
What symptoms can lupus nephritis cause?
Lupus nephritis may cause protein in the urine, swelling, or changes in urine. Some kidney involvement may not cause obvious symptoms, so regular blood and urine monitoring can help detect it early.
Why is a kidney biopsy used to diagnose lupus nephritis?
A kidney biopsy lets pathologists examine kidney tissue and look for patterns that support lupus nephritis. One important finding is “full-house” staining, in which several immune proteins are present together, but this result must be interpreted with the rest of the biopsy and the overall clinical picture.
What do activity and chronicity scores mean in lupus nephritis?
The activity score reflects current inflammation that may be reversible with treatment, while the chronicity score reflects established scarring that is more permanent. Together, these scores help clinicians estimate kidney damage and personalize treatment goals.
Does ancestry, age, or sex affect lupus nephritis risk?
Lupus nephritis is reported more often and may be more aggressive in people of non-European ancestry, including Black, Hispanic, and Indigenous populations. Children with lupus have a high risk of kidney involvement, and men with lupus nephritis may have a more severe course.
What should I ask my doctor about my lupus nephritis biopsy?
Ask which ISN/RPS biopsy class applies to you, what your activity and chronicity scores are, and whether the biopsy shows tubulointerstitial injury or scarring. These findings help your care team understand the pattern and extent of kidney involvement and plan monitoring and treatment.

Get notified when new evidence is published on Lupus nephritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (23)
  1. 1

    Lupus nephritis.

    Parodis I, Rovin BH, Tektonidou MG, et al.

    Nature reviews. Disease primers 2025; (11(1)):69 doi:10.1038/s41572-025-00653-y.

    PMID: 40998820
  2. 2

    Lupus nephritis: Biomarkers.

    Dobrowolski C, Lao SM, Kharouf F, et al.

    Advances in clinical chemistry 2025; (124()):87-122 doi:10.1016/bs.acc.2024.10.002.

    PMID: 39818439
  3. 3

    Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.

    Mahajan A, Amelio J, Gairy K, et al.

    Lupus 2020; (29(9)):1011-1020 doi:10.1177/0961203320932219.

    PMID: 32571142
  4. 4

    Genetics of human lupus nephritis.

    Iwamoto T, Niewold TB

    Clinical immunology (Orlando, Fla.) 2017; (185()):32-39 doi:10.1016/j.clim.2016.09.012.

    PMID: 27693588
  5. 5

    A Comprehensive and Practical Approach to the Management of Lupus Nephritis in the Current Era.

    Wiegley N, Arora S, Norouzi S, Rovin B

    Advances in kidney disease and health 2024; (31(3)):234-245 doi:10.1053/j.akdh.2023.11.003.

    PMID: 39004463
  6. 6

    Challenges in the care of patients with systemic lupus erythematosus and lupus nephritis in Latin America.

    Elera-Fitzcarrald C, Alarcón GS, Ugarte-Gil MF

    Expert opinion on pharmacotherapy 2025; (26(4)):447-455 doi:10.1080/14656566.2025.2464913.

    PMID: 39918839
  7. 7

    New Insights on Childhood Lupus Nephritis.

    Marchi-Silva R, De Aquino BM, Londe AC, et al.

    International journal of nephrology and renovascular disease 2025; (18()):1-12 doi:10.2147/IJNRD.S405789.

    PMID: 39829960
  8. 8

    Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.

    Mistry P, Kaplan MJ

    Clinical immunology (Orlando, Fla.) 2017; (185()):59-73 doi:10.1016/j.clim.2016.08.010.

    PMID: 27519955
  9. 9

    Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.

    Tsai CY, Li KJ, Shen CY, et al.

    International journal of molecular sciences 2023; (24(12)) doi:10.3390/ijms241210066.

    PMID: 37373215
  10. 10

    Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue.

    Kwant LE, Vegting Y, Tsang-A-Sjoe MWP, et al.

    Autoimmunity reviews 2022; (21(12)):103211 doi:10.1016/j.autrev.2022.103211.

    PMID: 36252930
  11. 11

    Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis.

    Yung S, Chan TM

    Clinical immunology (Orlando, Fla.) 2017; (185()):40-50 doi:10.1016/j.clim.2016.09.002.

    PMID: 27612436
  12. 12

    Expanding the Role of Complement Therapies: The Case for Lupus Nephritis.

    Li NL, Birmingham DJ, Rovin BH

    Journal of clinical medicine 2021; (10(4)) doi:10.3390/jcm10040626.

    PMID: 33562189
  13. 13

    The role of anticomplement therapy in lupus nephritis.

    Fernandez-Ruiz R, Belmont HM

    Translational research : the journal of laboratory and clinical medicine 2022; (245()):1-17 doi:10.1016/j.trsl.2022.02.001.

    PMID: 35158097
  14. 14

    Decoding Lupus Diagnosis, Pathogenesis and Therapy: From Systemic Autoimmunity to Renal Damage.

    Netti GS, Troise D, Infante B, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(14)) doi:10.3390/diagnostics16142170.

    PMID: 42510034
  15. 15

    The Role of Podocytes in Lupus Pathology.

    Maeda K, Abdi R, Tsokos GC

    Current rheumatology reports 2024; (27(1)):10 doi:10.1007/s11926-024-01175-4.

    PMID: 39731699
  16. 16

    Podocyte Injury in Lupus Nephritis.

    Sakhi H, Moktefi A, Bouachi K, et al.

    Journal of clinical medicine 2019; (8(9)) doi:10.3390/jcm8091340.

    PMID: 31470591
  17. 17

    Beyond glomeruli in lupus nephritis: Impact of tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy on renal function decline - A systematic review and meta-analysis.

    Donato KO, Donato AO, Gonçalves LF, et al.

    Lupus 2026; (35(7)):709-721 doi:10.1177/09612033261437467.

    PMID: 41860784
  18. 18

    Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies.

    Leatherwood C, Speyer CB, Feldman CH, et al.

    Seminars in arthritis and rheumatism 2019; (49(3)):396-404 doi:10.1016/j.semarthrit.2019.06.002.

    PMID: 31277928
  19. 19

    Sensitivity and Specificity of Pathologic Findings to Diagnose Lupus Nephritis.

    Kudose S, Santoriello D, Bomback AS, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2019; (14(11)):1605-1615 doi:10.2215/CJN.01570219.

    PMID: 31653670
  20. 20

    Analysis of the Sensitivity and Specificity of Histopathological Findings for Diagnosing Lupus Nephritis.

    da Luz Neto ER, Tavares MB, de Melo AGJT, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(23)) doi:10.3390/diagnostics14232681.

    PMID: 39682589
  21. 21

    Clinicopathological Pattern of Non-lupus Full House Nephropathy.

    Wani AS, Zahir Z, Gupta A, Agrawal V

    Indian journal of nephrology 2020; (30(5)):301-306 doi:10.4103/ijn.IJN_91_18.

    PMID: 33707816
  22. 22

    Histologic evaluation of activity and chronicity of lupus nephritis and its clinical significance.

    Choi SE, Fogo AB, Lim BJ

    Kidney research and clinical practice 2023; (42(2)):166-173 doi:10.23876/j.krcp.22.083.

    PMID: 37037479
  23. 23

    Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV.

    Bolognesi MM, Capitoli G, Galimberti S, et al.

    Annals of the rheumatic diseases 2022; (81(12)):1704-1711 doi:10.1136/ard-2022-222620.

    PMID: 35940846

This page explains how lupus can affect the kidneys for informational purposes only and does not constitute medical advice. Your rheumatologist and nephrologist should interpret your biopsy and lab results and guide your care.

Guide contents Lupus nephritis
Research & Literature
02 Lupus Nephritis